Prosecution Insights
Last updated: October 02, 2026

Examiner: FREDRICKSON, COURTNEY B

Tech Center 3700 • Art Units: 3763 3783 3795

This examiner grants 76% of resolved cases

Analysis

Within Tech Center 3700 and Art Unit 3763, Examiner Courtney B Fredrickson has handled 409 resolved cases. The allowance rate for these cases is 75.6 percent. This figure serves as a reference for the likelihood of success. A median days to allowance of 1145 defines the prosecution timeline. This duration is a consideration for applicants when managing their portfolios.

Data shows an interview lift of 29.5 percent. With 409 resolved cases, this lift indicates the impact of communication on results. The 1145 days to allowance provides a standard for pendency. The 75.6 percent allowance rate and the Art Unit 3763 designation help determine a prosecution approach for the case. These data points from Tech Center 3700 support planning for the patent process.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

75.6%
Allow Rate
+5.6% vs TC avg
447
Total Applications
+29.5%
Interview Lift
1145
Avg Prosecution Days
Based on 409 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
18.9%
§102 Novelty
41.3%
§103 Obviousness
30.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18794609 CATHETER SHAFT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS Non-Final OA Covidien LP
18753308 DEVICES AND METHODS FOR DELIVERING A BENEFICIAL AGENT TO A USER Non-Final OA ABBVIE INC.
18489058 DEVICES AND METHODS FOR DELIVERING A BENEFICIAL AGENT TO A USER Non-Final OA ABBVIE INC.
17748809 PURGE VALVE ASSEMBLIES SYSTEMS AND METHODS Final Rejection Regents of the University of Minnesota
18602650 TELESCOPIC TUBING EXTENSION SET Non-Final OA CareFusion 303, Inc.
18489691 PUMPS FOR IMPROVING FLUID DELIVERY AND METHODS OF USE THEREOF Final Rejection CareFusion 303, Inc.
17035058 MODULAR IN-LINE FILTER DEVICE Non-Final OA CareFusion 303, Inc.
18733259 SYSTEMS AND METHODS FOR ANALYZING SPENT DIALYSATE Non-Final OA FRESENIUS MEDICAL CARE HOLDINGS, INC.
18571873 Secondary Securement Device for Vascular Access Device Non-Final OA Becton, Dickinson and Company
18013392 MEDICAL STOPCOCK ASSEMBLY WITH POSITION DETECTION Non-Final OA Becton, Dickinson and Company
18267522 HOUSING COMPONENT OF AN INJECTION DEVICE COMPRISING A MAGNIFIER Non-Final OA Sanofi
18651029 CATHETER HUB WITH SEALED ACCESS PORT Non-Final OA Cook Medical Technologies LLC
18751761 HELICAL INSERTION INFUSION DEVICE Non-Final OA Tandem Diabetes Care, Inc.
18220156 INSULIN PUMP WITH INTEGRATED CONTINUOUS GLUCOSE MONITOR Non-Final OA Tandem Diabetes Care, Inc.
18022298 INFUSION OR TRANSFUSION SET AND SYSTEM COMPRISING AN INFUSION OR TRANSFUSION SET Final Rejection B. Braun Melsungen AG
17917873 Microneedle Array Delivery of Adenovirus Vectored Vaccines With and Without Adjuvants Final Rejection University of Pittsburgh - Of the Commonwealth System of Higher Education

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month